New concepts in device therapy for advanced heart failure presented in early reports ...

BrioHealth Solutions ( today announces the successful implantation of its 100th BrioVAD System, an investigational Ventricular Assist Device (VAD) designed to support patients with advanced heart ...

Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.

The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after implantation.

SynCardia Total Artificial Heart before receiving a donor heart transplant. TUCSON, Ariz., March 17, 2026 (GLOBE NEWS ...

A Monash-led research project is redefining mechanical heart support with a tailored pump designed for the millions of patients living with heart failure.

Picard Medical, Inc. (NYSE American: PMI) (the "Company"), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific ...

Naples Comprehensive Health (NCH) today announced plans to expand its premier cardiovascular service to include the foundation of an Advanced Heart Failure and Transplant program, reinforcing its ...

A 9-month-old little girl from Norman is waiting for a miracle, a new heart, after being born with a rare and life-threatening heart defect.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an update on its ongoing regulatory interactions with the U.S. Food and Drug ...